Body surface potential mapping detects early disease onset in plakophilin-2-pathogenic variant carriers

Manon Kloosterman1, Machteld J Boonstra1, Rob W Roudijk1

  • 1Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Insights

Body surface potential mapping (BSPM) detects subtle electrical abnormalities in arrhythmogenic right ventricular cardiomyopathy (ARVC) variant carriers, even when standard ECGs appear normal. This suggests electrical changes may precede structural heart disease.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Genetics

Background:

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive inherited heart disease.
  • Early detection and risk stratification are challenging due to varied symptoms.
  • Standard 12-lead ECGs may miss subtle abnormalities.

Purpose of the Study:

  • To investigate if body surface potential mapping (BSPM) is more sensitive than standard ECG for detecting early signs of ARVC.
  • To identify electrical abnormalities in carriers of plakophilin-2 (PKP2) pathogenic variants.

Main Methods:

  • Obtained 67-electrode BSPM in 42 PKP2 variant carriers and 25 controls.
  • Created subject-specific heart/torso models from CT/MRI for precise mapping.
  • Analyzed QRS and STT isopotential maps, correlating patterns with cardiac anatomy.
  • Acquired right ventricular (RV) echocardiographic deformation imaging for functional assessment.

Main Results:

  • Identified abnormal QRS and STT patterns in 31/42 PKP2 variant carriers using BSPM.
  • 17 of these carriers showed normal 12-lead ECGs.
  • In pre-clinical carriers, BSPM detected abnormalities in 7/12 with normal RV deformation.

Conclusions:

  • BSPM can detect depolarization and repolarization abnormalities in ARVC variant carriers missed by standard ECG.
  • Electrical abnormalities identified by BSPM may precede functional or structural changes in ARVC.
  • BSPM shows promise for early disease detection and risk stratification in ARVC.
Abstract